Camber intros theophylline extended-release tabletsTheophylline ER tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases. AAM: Avalere study shows PBMs continue to block patient access to biosimilarsThe analysis reiterates that biosimilar challenges are not limited to the Humira market. CSL Seqirus prepared to deliver 2024/25 U.S. season influenza vaccine portfolio The vaccine portfolio is based on the trivalent strains recommended by the FDA's Vaccines and Related Biological Products Advisory Committee. Knapp launches shuttle for freezer applications Knapp is releasing its OSR shuttle technology for cold chain applications and projects. Dr. Reddy’s intros Avastin biosimilar in the U.K. Versavo (bevacizumab) is indicated for the treatment of several types of cancers. Industry Issues Summit: How VillageMD is transforming health care A fireside chat at DSN’s Industry Issues Summit highlighted VillageMD’s focus on patient care. Endo confirms reorganization plans Endo anticipates completing financial restructuring as early as late April 2024. Avenacy debuts generic Lasix Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease. NACDS RxIMPACT announces 2024 Grassroots awards During the dinner program, NACDS Chair Mike Wysong, CEO of CARE Pharmacies, and NACDS president and CEO Steve Anderson presented the awards. Insud Pharma acquires Viatris' women's healthcare business The women’s healthcare business is primarily related to oral and injectable contraceptives. First Previous 62 63 64 65 66 Next Last
